Immunomodulation of human intestinal T cells by the synthetic CD80 antagonist RhuDex®
Deregulated activation of mucosal lamina propria T cells plays a central role in the pathogenesis of intestinal inflammation. One of the means to attenuate T cell activation is by blocking the CD28/CD80 co-stimulatory pathway. Here we investigate RhuDex®, a small molecule that binds to human CD80, f...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
3 November 2014
|
| In: |
Immunity, Inflammation and Disease
Year: 2014, Volume: 2, Issue: 3, Pages: 166-180 |
| ISSN: | 2050-4527 |
| DOI: | 10.1002/iid3.34 |
| Online Access: | Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1002/iid3.34 Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/iid3.34 |
| Author Notes: | Anne-Kristin Heninger, Sabine Wentrup, Mohammed Al‐Saeedi, Serin Schiessling, Thomas Giese, Florian Wartha, Stefan Meuer, & Jutta Schröder‐Braunstein |
| Summary: | Deregulated activation of mucosal lamina propria T cells plays a central role in the pathogenesis of intestinal inflammation. One of the means to attenuate T cell activation is by blocking the CD28/CD80 co-stimulatory pathway. Here we investigate RhuDex®, a small molecule that binds to human CD80, for its effects on the activation of lamina propria T cells employing a gut-culture model of inflammation. |
|---|---|
| Item Description: | Gesehen am 20.10.2020 |
| Physical Description: | Online Resource |
| ISSN: | 2050-4527 |
| DOI: | 10.1002/iid3.34 |